{
    "clinical_study": {
        "@rank": "104125", 
        "arm_group": [
            {
                "arm_group_label": "Femoral With Tibial Nerve Block", 
                "arm_group_type": "Active Comparator", 
                "description": "Continuous femoral nerve block with catheter and selective tibial nerve block in the popliteal fossa"
            }, 
            {
                "arm_group_label": "Canal Block and Capsular Injection", 
                "arm_group_type": "Experimental", 
                "description": "Adductor canal block with a continuous catheter and ultrasound guided posterior capsular injection with local anesthetic solution."
            }
        ], 
        "brief_summary": {
            "textblock": "To compare early ambulation and ability to participate in rehabilitation in patients\n      undergoing total knee replacement using two different nerve block techniques for pain\n      control. The 2 methods are 1) Adductor canal block with posterior capsular injection 2)\n      femoral nerve block with tibial nerve block"
        }, 
        "brief_title": "Adductor Canal Block With Posterior Capsular Injection for Total Knee Replacement", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pain", 
            "Osteoarthritis"
        ], 
        "condition_browse": {
            "mesh_term": "Osteoarthritis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients having primary, unilateral total knee arthroplasty\n\n          -  ages 18 - 80\n\n        Exclusion Criteria:\n\n          -  history of neurological disease\n\n          -  neuropathy\n\n          -  diabetes\n\n          -  major systemic illness\n\n          -  pregnancy\n\n          -  chronic narcotic use\n\n          -  allergy to local anesthetic solution or NSAIDS\n\n          -  inability to give consent or cooperate with the study protocol\n\n          -  BMI> 40"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01805661", 
            "org_study_id": "12-10-002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Canal Block and Capsular Injection", 
                "description": "Continuous Adductor canal block with 15-30ml of ropivacaine 0.1% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.1% at 6 ml per hour for 2 days post operatively.  This is combined with ultrasound guided posterior capsular knee injection with 30 ml ropivacaine 0.1% with epinephrine 1:400,000.", 
                "intervention_name": "Canal Block and Capsular Injection", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Femoral With Tibial Nerve Block", 
                "description": "Continuous femoral nerve block with 15 ml of ropivacaine 0.1% followed by an infusion of ropivacaine 0.1% at 6 ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.1% up to 15 ml.", 
                "intervention_name": "Femoral with Tibial Nerve Block", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "early ambulation", 
            "knee arthroplasty"
        ], 
        "lastchanged_date": "March 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hartford", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06105"
                }, 
                "name": "Saint Francis Hospital and Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of Early Ambulation and Participation in Rehabilitation Program in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection Versus Continuous Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement.", 
        "overall_official": {
            "affiliation": "Saint Francis Hospital and Medical Center", 
            "last_name": "Sanjay Sinha, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.", 
            "measure": "Ability to ambulate post operatively.", 
            "safety_issue": "No", 
            "time_frame": "Up to 3 days (72 hours) post surgery."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01805661"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 72 hour period after discharge from recovery room.", 
                "measure": "Pain scores at rest and with knee flexion.", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 days ( 72 hours) after surgery"
            }, 
            {
                "description": "Amount of opioid consumption post surgery for 72 hours.", 
                "measure": "Pain Medication Consumption", 
                "safety_issue": "No", 
                "time_frame": "Up to 3 days (72 hours) post surgery"
            }
        ], 
        "source": "Saint Francis Care", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Saint Francis Care", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}